Å·ÃÀAV

Introduction

The aim of the 4th Å·ÃÀAV-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with the theme, having over three-quarters of the presentations focused on case studies. The conference will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and X-ray screening.

Useful links

Downloads

• Delegate registration form.doc
• Fragments - final announcement.pdf

Sponsorship & supporting organisations

We are grateful to our sponsors evotec and Science & Technology Facilities Council

Venue

STFC Rutherford Appleton Laboratory

STFC Rutherford Appleton Laboratory, Harwell, Oxford, Didcot, OX11 0QX, United Kingdom

Useful links

Organised by

Organised by Å·ÃÀAV's Biological & Medicinal Chemistry Sector

Contact information

Mrs Maggi Churchouse
Maggi Churchouse Events, East Barn, Market Weston Road, Thelnetham, Diss, IP22 1JJ, United Kingdom
+ 44 (0)1359 221004
Contact us by email

---